Newsroom

csrxp

Vizient Joins CSRxP as 30th Member of the Coalition

“We are excited to join CSRxP and be a part of the coalition to achieve reasonable prescription drug prices,” says Jody Hatcher, president, sourcing and collaboration services at Vizient. “Our health care members are facing enormous financial and clinical pressures associated with pharmaceuticals.

Read more
csrxp

37 Signatories Call on Congress to Pass CREATES Act

37 signatories have called on Congress to pass the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. This coalition represents a broad-based and diverse cross-section of stakeholders – including providers and payers, physicians and consumers, businesses and unions – all of whom have come together in strong support of this important legislation.

Read more
pills

CSRxP Statement on Novartis’ $475,000 Price Tag for Kymriah

“While we are very excited about the potential for CAR-T therapies to save lives, Novartis’ pricing decision disappointingly pushes an unsustainable trend even closer to the breaking point.”

Read more
csrxp

CSRxP Calls for Action on CREATES Act

CSRxP Calls for Action on CREATES Act The Campaign for Sustainable Rx Pricing released this statement from spokesman Will Holley on today’s House Judiciary Subcommittee on […]

Read more